- BBC News World
The US Federal Bureau of Drug Administration (FDA) on Wednesday approved the first home-use tablet for the treatment of Govit-19, manufactured by Pfizer Labs.
People over the age of 12 can use this pill at risk. FDA approval for emergency use.
“Today’s recognition offers the first treatment for Govit-19 in oral tablet form. A big breakthrough in the fight against this epidemicPatrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research, said in a statement.
A medical examination by Pfizer revealed the presence of the pill 90% eficaz To prevent hospitalization and death In high-risk patients.
Recent laboratory data suggest that this drug also maintains its effectiveness against Omigran, a variant of anxiety found in South Africa in late November, and that it is spreading rapidly around the world.
The drug should only be available if prescribed and treatment should begin within the first five days of the patient reporting symptoms, the FDA added.
Each treatment with these pills – to be taken every 12 hours for five days as soon as symptoms appear – is priced at US $ 530, according to the US government’s agreement with Pfizer.
The lab has announced that it is ready to supply the drug in the United States and has increased its production estimates from 80 million to 120 million (10 tablets) by 2022.
The German laboratory Merck contains an anticoagulant pill under review by the FDA, although clinical trials have shown a 30% effectiveness in preventing hospital admissions and deaths from COVID-19.
Now you can get notifications from BBC Mundo. Download the latest version of our apps and activate them so you don’t miss out on our great content.